This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Simon Leung: Innovator in Hydroxyazapirones
Introduction
Simon Leung is a notable inventor based in Piscataway, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of processes for synthesizing complex compounds. His work is characterized by a focus on practical applications and large-scale production.
Latest Patents
Simon Leung holds a patent for a process titled "Process for hydroxyazapirones." This invention describes a method for preparing hydroxyazapirones of Formula I from azapirones of Formula II. The process involves treating azapirones with a strong base, monitoring enolate formation of the azapirone by IR spectroscopy, and reacting the enolate with a source of molecular oxygen in the presence of a reductant. This innovative process is suitable for large-scale production of hydroxyazapirones, showcasing Leung's expertise in chemical synthesis.
Career Highlights
Leung is currently employed at Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His role involves research and development, where he applies his knowledge to advance pharmaceutical innovations. His contributions have been instrumental in enhancing the company's product offerings and improving therapeutic options for patients.
Collaborations
Simon Leung has collaborated with esteemed colleagues such as Jeffrey Depue and Atul S Kotnis. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their respective fields.
Conclusion
In summary, Simon Leung is a distinguished inventor whose work in the synthesis of hydroxyazapirones has made a significant impact in the field of chemistry. His dedication to innovation and collaboration continues to inspire advancements in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
